Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, Simone
  • Lorenzo Bermejo, Justo|||0000-0002-6568-5333
  • Chang-Claude, Jenny
  • Hoffmeister, Michael
  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Castells, Antoni|||0000-0001-8431-2033
  • Piñol, Virgínia
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Gonzalo, Victoria|||0000-0003-4611-5463
  • Ocaña, Teresa
  • Serradesanferm, Anna
  • Moreira, Leticia
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Piqué, Josep, M.
  • Ángel, L.
  • Javier, A.
  • Javier, O.
  • Cubiella, Joaquín|||0000-0002-9994-4831
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Abulí, Anna|||0000-0001-9894-0639
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Iglesias, Mar|||0000-0002-2274-4671
  • Seoane, Agustín|||0000-0001-8023-4445
  • Bory, Felipe
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Dedeu, Josep Maria|||0000-0003-0522-1032
  • Cristina, A.
  • Puigvehí, Marc|||0000-0002-3694-3241
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, D.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Cuquerella, Jaime
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Vicent, H.
  • Llor, Xavier|||0000-0002-6259-185X
  • Xicola, Rosa M.|||0000-0001-6466-1885
  • Piñol Pascual, Marta
  • Rosinach, Mercè
  • Roca, Anna
  • Pons, Elisenda
  • Hernández, José
  • Gassull Durò, Miquel Àngel|||0000-0001-7751-4833
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, Esther|||0000-0002-2777-0000
  • Montserrat, F.
  • Maria, E.
  • Reñé, Josep Maria
  • Piñol, Carmen
  • Buenestado, Juan
  • Viñas, Joan
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • González, Dolors
  • Roman, Eva|||0000-0001-9084-8555
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Concepción, Mar|||0000-0003-1821-0359
  • Martín Flix, Marta|||0000-0001-7849-3616
  • Pétriz, Lourdes
  • Daniel, M.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth-Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz-Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, Henry|||0000-0001-7003-399X
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts. © 2013 Picelli et al.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Family physicians' attitudes and practice on screening and prevention of fragility fractures, and shared decision-making with postmenopausal women, a qualitative study in Spain

  • León-García, Montserrat|||0000-0001-8567-4685
  • Cánovas Martínez, Esther|||0000-0001-7351-9389
  • Álvarez Pérez, Yolanda
  • Pou, María Antonia
  • López García-Franco, Alberto
  • Sanz Bas, Ana
  • Rodriguez-Moreno, Sara
  • Delgado Espinoza, Claudia Erika|||0009-0009-9089-4784
  • Roca, Pablo|||0000-0001-9815-4902
  • González Osuna, Aránzazu|||0000-0002-2436-9035
  • Fernández Valverde, Diana Elisabeth|||0000-0002-4665-729X
  • Marín Nanco, Betzabeth|||0000-0002-2446-8391
  • Medina-Aedo, Melixa|||0000-0002-9922-464X
  • Perestelo-Pérez, Lilisbeth|||0000-0002-6113-7313
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Osteoporosis is a prevalent condition among postmenopausal women, significantly increasing the risk of fragility fractures. Despite the availability of clinical guidelines, their implementation in primary care, remains highly variable, particularly regarding fracture prevention and shared decision-making (SDM). We conducted a qualitative study to explore the attitudes and practices of Spanish family physicians in preventing fractures among postmenopausal women. Sixteen semi-structured interviews were conducted with physicians from diverse socioeconomic backgrounds and levels of clinical experience. Data were analysed using an iterative, theory-driven approach to identify key themes and barriers. Physicians showed substantial variability in fracture risk assessment approaches, frequently combining tools such as FRAX with clinical judgment. Most were cautious about prescribing bisphosphonates for primary prevention, citing concerns about the strength of the evidence and potential adverse effects. While non-pharmacological strategies, such as lifestyle modifications and fall prevention, were emphasized, their implementation was often constrained by workload pressures. Patient involvement in decision-making was hindered by widespread misconceptions about osteoporosis and its treatment, as well as the lack of appropriate decision-support tools. Participants highlighted the need for clearer guidelines, enhanced educational resources, and accessible decision aids to facilitate patient engagement in care. This study highlights the complex challenges family physicians face in fracture prevention among postmenopausal women, including heterogeneity of recommendations in guidelines, limited SDM implementation, and systemic barriers within primary care. Addressing these issues will require multifaceted interventions targeting both healthcare system constraints and patient education. Future efforts should focus on developing and implementing strategies that support evidence-based, patient-centred decision-making while accounting for the realities of primary care practice.
Repisalud
Publication Artículo científico (JournalArticle)

Transferable AmpCs in Klebsiella pneumoniae: interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications

  • Barceló, Isabel M
  • Escobar-Salom, Maria
  • Cabot, Gabriel
  • Perelló-Bauzà, Pau
  • Jordana-Lluch, Elena
  • Taltavull, Biel
  • Torrens, Gabriel
  • Rojo-Molinero, Estrella
  • Zamorano, Laura
  • Perez Gomez, Astrid
  • Oliver, Antonio
  • Juan, Carlos
Chromosomal and transferable AmpC β-lactamases represent top resistance mechanisms in different gram-negatives, but knowledge regarding the latter, mostly concerning regulation and virulence-related implications, is far from being complete. To fill this gap, we used Klebsiella pneumoniae (KP) and two different plasmid-encoded AmpCs [DHA-1 (AmpR regulator linked, inducible) and CMY-2 (constitutive)] as models to perform a study in which we show that blockade of peptidoglycan recycling through AmpG permease inactivation abolished DHA-1 inducibility but did not affect CMY-2 production and neither did it alter KP pathogenic behavior. Moreover, whereas regular production of both AmpC-type enzymes did not attenuate KP virulence, when blaDHA-1 was expressed in an ampG-defective mutant, Galleria mellonella killing was significantly (but not drastically) attenuated. Spontaneous DHA-1 hyperproducer mutants were readily obtained in vitro, showing slight or insignificant virulence attenuations together with high-level resistance to β-lactams only mildly affected by basal production (e.g., ceftazidime, ceftolozane/tazobactam). By analyzing diverse DHA-1-harboring clinical KP strains, we demonstrate that the natural selection of these hyperproducers is not exceptional (>10% of the collection), whereas mutational inactivation of the typical AmpC hyperproduction-related gene mpl was the most frequent underlying mechanism. The potential silent dissemination of this kind of strains, for which an important fitness cost-related contention barrier does not seem to exist, is envisaged as a neglected threat for most β-lactams effectiveness, including recently introduced combinations. Analyzing whether this phenomenon is applicable to other transferable β-lactamases and species as well as determining the levels of conferred resistance poses an essential topic to be addressed. IMPORTANCE: Although there is solid knowledge about the regulation of transferable and especially chromosomal AmpC β-lactamases in Enterobacterales, there are still gaps to fill, mainly related to regulatory mechanisms and virulence interplays of the former. This work addresses them using Klebsiella pneumoniae as model, delving into a barely explored conception: the acquisition of a plasmid-encoded inducible AmpC-type enzyme whose production can be increased through selection of chromosomal mutations, entailing dramatically increased resistance compared to basal expression but minor associated virulence costs. Accordingly, we demonstrate that clinical K. pneumoniae DHA-1 hyperproducer strains are not exceptional. Through this study, we warn for the first time that this phenomenon may be a neglected new threat for β-lactams effectiveness (including some recently introduced ones) silently spreading in the clinical context, not only in K. pneumoniae but potentially also in other pathogens. These facts must be carefully considered in order to design future resistance-preventive strategies.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Relaxin‑2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

  • Aragón Herrera, Alana
  • Couselo Seijas, Marinela
  • Feijóo Bandín, Sandra
  • Anido Varela, Laura
  • Moraña Fernández, Sandra
  • Tarazón, Estefanía
  • Roselló-Lletí, Esther
  • Portolés, Manuel
  • Martínez Sande, José Luis
  • García Seara, Javier
  • Álvarez Castro, Ezequiel
  • González Juanatey, José Ramón
  • Rodríguez Mañero, Moisés
  • Eiras Penas, Sonia
  • Lago Paz, María Francisca
Relaxin-2 exerts many favourable cardiovascular effects in pathological circumstances such as atrial fibrillation (AF) and heart failure, but the mechanisms underlying its actions are not completely understood. Since inflammation and fibrosis are pivotal processes in the pathogenesis of AF, our aim was to study the relationship between relaxin-2 plasma levels in left atrium (LA) and peripheral vein with molecules implicated in fibrosis, inflammation and oxidative stress in AF patients, and to evaluate the anti-fibrotic ability of relaxin-2 in normal human atrial cardiac fibroblasts (NHCF-A). Peripheral vein relaxin-2 plasma levels were higher than LA relaxin-2 plasma levels in men while, in women, peripheral vein relaxin-2 levels were increased compared to men. AF patients with higher levels of relaxin-2 exhibited a reduction in H2O2 plasma levels and in mRNA levels of alpha-defensin 3 (DEFA3) and IL-6 in leucocytes from LA plasma. Relaxin-2-in-vitro treatment inhibited NHCF-A migration and decreased mRNA and protein levels of the pro-fibrotic molecule transforming growth factor-β1 (TGF-β1). Our results support an association between relaxin-2 and molecules involved in fibrosis, inflammation and oxidative stress in AF patients, and reinforce an anti-fibrotic protective role of this hormone in NHCF-A; strengthening the relevance of relaxin-2 in AF physiopathology, diagnosis and treatment.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

  • Aragón Herrera, Alana
  • Otero-Santiago, Manuel
  • Anido Varela, Laura
  • Moraña Fernández, Sandra
  • Campos-Toimil, Manuel
  • García-Caballero, Tomás
  • Barral, Luis
  • Tarazón, Estefanía
  • Roselló-Lletí, Esther
  • Portolés, Manuel
  • Gualillo, Oreste
  • Moscoso, Isabel
  • Lage Fernández, Ricardo
  • González-Juanatey, José Ramón
  • Feijóo-Bandín, Sandra
  • Lago, Francisca
[Abstract] The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of patients with diabetes and cardiovascular disease. Recent evidences have shown the benefits of the SGLT2 inhibitor empagliflozin on improving liver steatosis and fibrosis in patients with T2DM. Metabolomic studies have been shown to be very useful to improve the understanding of liver pathophysiology during the development and progression of metabolic hepatic diseases, and because the effects of empagliflozin and of other SGLT2 inhibitors on the complete metabolic profile of the liver has never been analysed before, we decided to study the impact on the liver of male Zucker diabetic fatty (ZDF) rats of a treatment for 6 weeks with empagliflozin using an untargeted metabolomics approach, with the purpose to help to clarify the benefits of the use of empagliflozin at hepatic level. We found that empagliflozin is able to change the hepatic lipidome towards a protective profile, through an increase of monounsaturated and polyunsaturated glycerides, phosphatidylcholines, phosphatidylethanolamines, lysophosphatidylinositols and lysophosphatidylcholines. Empagliflozin also induces a decrease in the levels of the markers of inflammation IL-6, chemerin and chemerin receptor in the liver. Our results provide new evidences regarding the molecular pathways through which empagliflozin could exert hepatoprotector beneficial effects in T2DM., This work was supported by Boehringer Ingelheim Pharma GmbH and Co., by the National Institute of Health “Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III” Madrid, Spain (PI15/00681, PI17/00409, PI18/00821, PI20/00902, RETICS Programme RD16/0012/0014 and CIBER de Enfermedades Cardiovasculares (CIBERCV)); European Regional Development Fund (FEDER) and European Union framework MSCA-RISE-H2020 Programme (Project number 734899). AH-A was funded by predoctoral research grants from Xunta de Galicia and FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); MF-S was funded by the predoctoral research grants “Programa Científico do Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS) (Spain) and Xunta de Galicia; and AV-L was funded by the predoctoral research grant from the PFIS Program of the Spanish Ministry of Science and Instituto de Salud Carlos III (Spain)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, S.
  • Lorenzo Bermejo, J.
  • Chang Claude, J.
  • Hoffmeister, M.
  • Fernández Rozadilla, C.
  • Carracedo, A.
  • Castells, A.
  • Castellví Bel, S.
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Antoni, C.
  • Virgínia, P.
  • Sergi, C.B.
  • Balaguer, F.
  • Victoria, G.
  • Teresa, O.
  • María Dolores, G.
  • Maria, P.
  • Anna, S.
  • Leticia, M.
  • Miriam, C.
  • Josep, M.P.
  • Lanas, A.
  • Alcedo, J.
  • Ortego, F.J.
  • Joaquin, C.
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Montserrat, A.
  • Anna, A.
  • Xavier, B.
  • Mar, I.
  • Agustín, S.
  • Felipe, B.
  • Gemma, N.
  • Beatriz, B.
  • De Josep, M.
  • Cristina, Á.
  • Marc, P.
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, d.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Cristina, A.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Jaime, C.
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Jaime, S.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Antoni, T.
  • Juan, C.
  • Vicent, H.
  • Xavier, L.
  • Rosa, M.X.
  • Marta, P.
  • Mercè, R.
  • Anna, R.
  • Elisenda, P.
  • José, M.H.
  • Miquel, A.G.
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, E.
  • Montserrat, F.
  • Maria, E.
  • Josep, M.R.
  • Carmen, P.
  • Juan, B.
  • Joan, V.
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • Dolors, G.
  • Eva, R.
  • Teresa, R.
  • Maria, P.
  • Ma, M.C.
  • Marta, M.
  • Lourdes, P.
  • Daniel, M.
  • Ángel, C.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno, V.
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, H.
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Álvarez-Barona, Miriam|||0000-0002-3843-7481
  • Quintana, Isabel
  • López-Novo, Jorge Amigo
  • Amigo, Jorge|||0000-0002-1362-2605
  • Cameselle-Teijeiro, José Manuel|||0000-0002-5516-8914
  • Roman, Eva|||0000-0001-9084-8555
  • Gonzalez, Dolors
  • Llor, Xavier|||0000-0002-6259-185X
  • Bujanda, Luis|||0000-0002-4353-9968
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Jover, Rodrigo
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Capella, Gabriel|||0000-0002-4669-7320
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Valle, Laura|||0000-0003-0371-0844
  • Ruiz-Ponte, Clara|||0000-0002-2200-0162
Colorectal cancer (CRC) is a complex disease that can be caused by a spectrum of genetic variants ranging from low to high penetrance changes, that interact with the environment to determine which individuals will develop the disease. In this study, we sequenced 20 early-onset CRC patients to discover novel genetic variants that could be linked to the prompt disease development. Eight genes, CHAD, CHD1L, ERCC6, IGTB7, PTPN13, SPATA20, TDG and TGS1, were selected and re-sequenced in a further 304 early onset CRC patients to search for rare, high-impact variants. Although we found a recurring truncating variant in the TDG gene shared by two independent patients, the results obtained did not help consolidate any of the candidates as promising CRC predisposing genes. However, we found that potential risk alleles in our extended list of candidate variants have a tendency to appear at higher numbers in younger cases. This supports the idea that CRC onset may be oligogenic in nature and may show molecular heterogeneity. Further, larger and robust studies are thus needed to unravel the genetics behind early-onset CRC development, coupled with novel functional analyses and omic approaches that may offer complementary insight.